tert-Butyl 3-[(3,4-difluorophenyl)methyl]-4-oxo-3H,4H,5H,6H,7H,8H-pyrido[4,3-d]pyrimidine-6-carboxylate

Catalog No. :
ACPUAR230
CAS No. :
1798531-26-6
Molecular Formula :
C19H21F2N3O3
Molecular Weight :
377.39

IUPAC Name:tert-butyl 3-(3,4-difluorobenzyl)-4-oxo-3,5,7,8-tetrahydropyrido[4,3-d]pyrimidine-6(4H)-carboxylate

tert-Butyl 3-[(3,4-difluorophenyl)methyl]-4-oxo-3H,4H,5H,6H,7H,8H-pyrido[4,3-d]pyrimidine-6-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g97%$323.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nametert-Butyl 3-[(3,4-difluorophenyl)methyl]-4-oxo-3H,4H,5H,6H,7H,8H-pyrido[4,3-d]pyrimidine-6-carboxylate
IUPAC Nametert-butyl 3-(3,4-difluorobenzyl)-4-oxo-3,5,7,8-tetrahydropyrido[4,3-d]pyrimidine-6(4H)-carboxylate
MDL No.MFCD28016176
Molecular FormulaC19H21F2N3O3
Molecular Weight377.39
SMILESO=C(N(C1)CCC(N=CN2CC3=CC=C(F)C(F)=C3)=C1C2=O)OC(C)(C)C
InChI KeyVPTCBWJQAOVRLE-UHFFFAOYSA-N
Synonymtert-butyl 3-[(3,4-difluorophenyl)methyl]-4-oxo-3H,4H,5H,6H,7H,8H-pyrido[4,3-d]pyrimidine-6-carboxylate;Pyrido[4,3-d]pyrimidine-6(4H)-carboxylic acid, 3-[(3,4-difluorophenyl)methyl]-3,5,7,8-tetrahydro-4-oxo-, 1,1-dimethylethyl ester
CAS No.1798531-26-6

Synthetic Route by SureRoute

1. ACPUAR230 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACGKPE427 route compound structure diagram
    ACGKPE42785118-01-0 In Stock
  4. Then
  5. ACPUAR230 route product structure diagram
    ACPUAR2301798531-26-6
Inquiry

2. ACPUAR230 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACPUAR230 route product structure diagram
    ACPUAR2301798531-26-6
Inquiry

Comments (0)